Radioimmunoassay evidence that the pressor effect of big endothelindash1 is due to local conversion to endothelindash1
- 31 January 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (3), 375-380
- https://doi.org/10.1016/0006-2952(94)00425-l
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- In Vivo Pharmacology of Ro 46-2005, The First Synthetic Nonpeptide Endothelin Receptor Antagonist: Implications for Endothelin PhysiologyJournal of Cardiovascular Pharmacology, 1993
- Why Big Endothelin-1 Lacks a Vasodilator ResponseJournal of Cardiovascular Pharmacology, 1993
- Effects of Phosphoramidon in Endothelial Cell Cultures on the Endogenous Synthesis of Endothelin-1 and on Conversion of Exogenous Big Endothelin-1 to Endothelin-1Journal of Cardiovascular Pharmacology, 1993
- Responses to endothelin-1, human proendothelin (1–38) and porcine proendothelin (1–39) in the rat on intravenous administration and in the blood perfused mesenteryNeurochemistry International, 1991
- Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cellsFEBS Letters, 1991
- Phosporamidon inhibits the vasoconstrictor effects evoked by big endothelin-1 but not the elevation of plasma endothelin-1 in vivoLife Sciences, 1991
- Inhibition of biological actions of big endothelin-1 by phosphoramidonBiochemical and Biophysical Research Communications, 1990
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivoFEBS Letters, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988